Stratasys PolyJet technology and Materialise FDA-cleared software now most versatile 3D printing system for hospitals and physicians to build anatomical models at the point-of-care.
MINNEAPOLIS & REHOVOT, Israel-(BUSINESS WIRE)-Nov. 26, 2018- Further bringing 3D printed medical models to life, Stratasys is expanding the suite of printers and materials validated by its collaborator Materialise as part of FDA-cleared Materialise Mimics inPrint software.
“The addition of multi-color and multi-material printers to the list of validated printers is aimed to enable healthcare providers to implement a versatile offering that can support their most complex cases across a wide range of surgical specialties on a single printer. At Materialise, we take a hardware-agnostic approach to software development, offering the flexibility to partner with other leaders in the 3D printing industry like Stratasys – a company committed to addressing requirements of the medical community.”
Materialise incorporates 27 years of 3D printing experience into a range of software solutions and 3D printing services, which together form the backbone of the 3D printing industry.
The Stratasys 3D printing ecosystem of solutions and expertise includes: 3D printers, materials, software, expert services, and on-demand parts production.
The statements in this press release relating to Stratasys’ beliefs regarding the benefits consumers will experience from the Stratasys J750, Objet30 Prime 3D Printers or their validation with Materialise, Stratasys’ expectation on the timing of shipping the Stratasys J750, Objet30 Prime 3D Printers or their validation with Materialise, are forward-looking statements reflecting management’s current expectations and beliefs.
These risks and uncertainties include, but are not limited to: the risk that consumers will not perceive the benefits of the Stratasys J750, Objet30 Prime 3D Printers or their validation with Materialise to be the same as Stratasys does; the risk that unforeseen technical difficulties will delay the shipping of the Stratasys J750, Objet30 Prime 3D Printers or their validation with Materialise; and other risk factors set forth under the caption “Risk Factors” in Stratasys’ most recent Annual Report on Form 20-F, filed with the Securities and Exchange Commission February 28, 2018.
This article was summarized automatically with AI / Article-Σ ™/ BuildR BOT™.